US Stock MarketDetailed Quotes

Amylyx Pharmaceuticals (AMLX)

Watchlist
  • 17.040
  • -0.280-1.62%
Close Apr 24 16:00 ET
  • 17.040
  • 0.0000.00%
Post 17:17 ET
1.89BMarket Cap-11.14P/E (TTM)

Amylyx Pharmaceuticals (AMLX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
26.43%-123.34M
52.71%-27.9M
26.95%-30.37M
62.08%-25.25M
-8,043.97%-39.82M
-1,506.55%-167.65M
-535.45%-59.01M
-704.22%-41.57M
-873.38%-66.58M
90.36%-489K
Net income from continuing operations
52.03%-144.74M
12.11%-33M
52.70%-34.39M
42.99%-41.44M
69.77%-35.91M
-712.42%-301.74M
-893.62%-37.55M
-447.98%-72.7M
-429.35%-72.7M
-7,652.00%-118.79M
Depreciation and amortization
-41.92%525K
-32.50%108K
-45.70%120K
-32.21%141K
-50.48%156K
-16.91%904K
-46.84%160K
-26.82%221K
-25.98%208K
54.41%315K
Other non cash items
-100.45%-169K
-430.53%-433K
--0
----
----
--37.16M
--131K
--36.2M
--805K
--22K
Change In working capital
97.64%-1.08M
100.34%92K
81.74%-1.94M
214.58%9.96M
-5,711.59%-9.2M
30.20%-45.83M
-1,815.03%-26.7M
68.89%-10.6M
59.95%-8.7M
101.43%164K
-Change in receivables
-99.04%383K
-96.27%50K
-103.79%-85K
-98.76%205K
-98.93%213K
261.50%39.96M
112.10%1.34M
-53.71%2.24M
200.22%16.56M
1,092.74%19.82M
-Change in inventory
--0
--0
--0
--0
--0
87.35%-9.25M
--0
--0
--0
30.44%-9.25M
-Change in prepaid assets
48.93%3.98M
124.18%682K
-183.90%-3.22M
55.73%5.86M
131.65%666K
182.92%2.68M
-164.55%-2.82M
161.15%3.84M
140.47%3.76M
27.00%-2.1M
-Change in payables and accrued expense
92.37%-6.02M
96.25%-934K
106.40%1.06M
113.34%3.87M
-18.78%-10.01M
-310.55%-78.91M
-168.11%-24.92M
10.48%-16.6M
-329.20%-28.96M
-224.14%-8.43M
-Change in other current assets
-11.46%1.73M
-5.90%271K
-31.71%336K
19.72%595K
-22.01%528K
--1.95M
--288K
10.81%492K
11.69%497K
55.28%677K
-Change in other current liabilities
48.49%-1.16M
103.92%23K
95.30%-27K
-1.08%-559K
-10.31%-599K
-10.53%-2.26M
-10.15%-586K
-10.60%-574K
-10.82%-553K
-10.59%-543K
Cash from discontinued investing activities
Operating cash flow
26.43%-123.34M
52.71%-27.9M
26.95%-30.37M
62.08%-25.25M
-8,043.97%-39.82M
-1,506.55%-167.65M
-535.45%-59.01M
-704.22%-41.57M
-873.38%-66.58M
90.36%-489K
Investing cash flow
Cash flow from continuing investing activities
-81.44%14.04M
-54.65%29.47M
-86.51%5.24M
179.40%22.99M
-5,430.77%-43.66M
-17.81%75.65M
210.54%64.98M
135.91%38.82M
-123.50%-28.96M
-98.54%819K
Net PPE purchase and sale
12.10%-138K
-330.00%-86K
-226.32%-24K
80.90%-17K
83.58%-11K
87.35%-157K
94.38%-20K
105.32%19K
67.99%-89K
73.20%-67K
Net investment purchase and sale
-87.34%14.18M
-54.53%29.55M
-92.99%5.26M
179.70%23.01M
-5,026.41%-43.65M
20.07%112.01M
205.44%65M
169.62%75M
-123.38%-28.87M
-98.42%886K
Net other investing changes
----
----
----
----
----
---36.2M
--0
----
----
----
Cash from discontinued investing activities
Investing cash flow
-81.44%14.04M
-54.65%29.47M
-86.51%5.24M
179.40%22.99M
-5,430.77%-43.66M
-17.81%75.65M
210.54%64.98M
135.91%38.82M
-123.50%-28.96M
-98.54%819K
Financing cash flow
Cash flow from continuing financing activities
73,758.91%257.03M
-289.09%-208K
239,407.50%191.61M
-214.81%-31K
50,023.66%65.66M
-90.18%348K
-52.17%110K
-91.00%80K
-98.05%27K
-87.40%131K
Proceeds from stock option exercised by employees
91.23%4.08M
154.05%376K
441.55%2.66M
53.19%72K
-32.92%970K
-69.52%2.13M
-57.35%148K
-50.10%491K
-97.79%47K
-59.14%1.45M
Net other financing activities
14,278.92%252.95M
-1,436.84%-584K
46,072.51%188.95M
-415.00%-103K
5,019.54%64.69M
48.30%-1.78M
67.52%-38K
-332.63%-411K
97.30%-20K
47.38%-1.32M
Cash from discontinued financing activities
Financing cash flow
73,758.91%257.03M
-289.09%-208K
239,407.50%191.61M
-214.81%-31K
50,023.66%65.66M
-90.18%348K
-52.17%110K
-91.00%80K
-98.05%27K
-87.40%131K
Net cash flow
Beginning cash position
-53.87%78.84M
208.63%226.16M
-21.37%59.54M
-64.26%61.21M
-53.87%78.84M
170.25%170.92M
-46.11%73.28M
-69.53%75.72M
48.57%171.27M
170.25%170.92M
Current changes in cash
261.19%147.73M
-77.69%1.36M
6,325.65%166.47M
97.61%-2.29M
-3,965.73%-17.82M
-185.24%-91.65M
-82.48%6.08M
97.62%-2.67M
-171.70%-95.51M
-99.11%461K
Effect of exchange rate changes
345.21%1.07M
122.48%118K
-36.02%151K
1,658.97%608K
279.09%197K
-373.75%-438K
-321.52%-525K
276.12%236K
-116.67%-39K
-246.67%-110K
End cash Position
188.74%227.64M
188.74%227.64M
208.63%226.16M
-21.37%59.54M
-64.26%61.21M
-53.87%78.84M
-53.87%78.84M
-46.11%73.28M
-69.53%75.72M
48.57%171.27M
Free cash flow
26.41%-123.48M
52.58%-27.99M
26.86%-30.39M
62.10%-25.27M
-7,064.57%-39.84M
-1,671.49%-167.8M
-547.35%-59.03M
-651.92%-41.55M
-900.25%-66.67M
89.55%-556K
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 26.43%-123.34M52.71%-27.9M26.95%-30.37M62.08%-25.25M-8,043.97%-39.82M-1,506.55%-167.65M-535.45%-59.01M-704.22%-41.57M-873.38%-66.58M90.36%-489K
Net income from continuing operations 52.03%-144.74M12.11%-33M52.70%-34.39M42.99%-41.44M69.77%-35.91M-712.42%-301.74M-893.62%-37.55M-447.98%-72.7M-429.35%-72.7M-7,652.00%-118.79M
Depreciation and amortization -41.92%525K-32.50%108K-45.70%120K-32.21%141K-50.48%156K-16.91%904K-46.84%160K-26.82%221K-25.98%208K54.41%315K
Other non cash items -100.45%-169K-430.53%-433K--0----------37.16M--131K--36.2M--805K--22K
Change In working capital 97.64%-1.08M100.34%92K81.74%-1.94M214.58%9.96M-5,711.59%-9.2M30.20%-45.83M-1,815.03%-26.7M68.89%-10.6M59.95%-8.7M101.43%164K
-Change in receivables -99.04%383K-96.27%50K-103.79%-85K-98.76%205K-98.93%213K261.50%39.96M112.10%1.34M-53.71%2.24M200.22%16.56M1,092.74%19.82M
-Change in inventory --0--0--0--0--087.35%-9.25M--0--0--030.44%-9.25M
-Change in prepaid assets 48.93%3.98M124.18%682K-183.90%-3.22M55.73%5.86M131.65%666K182.92%2.68M-164.55%-2.82M161.15%3.84M140.47%3.76M27.00%-2.1M
-Change in payables and accrued expense 92.37%-6.02M96.25%-934K106.40%1.06M113.34%3.87M-18.78%-10.01M-310.55%-78.91M-168.11%-24.92M10.48%-16.6M-329.20%-28.96M-224.14%-8.43M
-Change in other current assets -11.46%1.73M-5.90%271K-31.71%336K19.72%595K-22.01%528K--1.95M--288K10.81%492K11.69%497K55.28%677K
-Change in other current liabilities 48.49%-1.16M103.92%23K95.30%-27K-1.08%-559K-10.31%-599K-10.53%-2.26M-10.15%-586K-10.60%-574K-10.82%-553K-10.59%-543K
Cash from discontinued investing activities
Operating cash flow 26.43%-123.34M52.71%-27.9M26.95%-30.37M62.08%-25.25M-8,043.97%-39.82M-1,506.55%-167.65M-535.45%-59.01M-704.22%-41.57M-873.38%-66.58M90.36%-489K
Investing cash flow
Cash flow from continuing investing activities -81.44%14.04M-54.65%29.47M-86.51%5.24M179.40%22.99M-5,430.77%-43.66M-17.81%75.65M210.54%64.98M135.91%38.82M-123.50%-28.96M-98.54%819K
Net PPE purchase and sale 12.10%-138K-330.00%-86K-226.32%-24K80.90%-17K83.58%-11K87.35%-157K94.38%-20K105.32%19K67.99%-89K73.20%-67K
Net investment purchase and sale -87.34%14.18M-54.53%29.55M-92.99%5.26M179.70%23.01M-5,026.41%-43.65M20.07%112.01M205.44%65M169.62%75M-123.38%-28.87M-98.42%886K
Net other investing changes -----------------------36.2M--0------------
Cash from discontinued investing activities
Investing cash flow -81.44%14.04M-54.65%29.47M-86.51%5.24M179.40%22.99M-5,430.77%-43.66M-17.81%75.65M210.54%64.98M135.91%38.82M-123.50%-28.96M-98.54%819K
Financing cash flow
Cash flow from continuing financing activities 73,758.91%257.03M-289.09%-208K239,407.50%191.61M-214.81%-31K50,023.66%65.66M-90.18%348K-52.17%110K-91.00%80K-98.05%27K-87.40%131K
Proceeds from stock option exercised by employees 91.23%4.08M154.05%376K441.55%2.66M53.19%72K-32.92%970K-69.52%2.13M-57.35%148K-50.10%491K-97.79%47K-59.14%1.45M
Net other financing activities 14,278.92%252.95M-1,436.84%-584K46,072.51%188.95M-415.00%-103K5,019.54%64.69M48.30%-1.78M67.52%-38K-332.63%-411K97.30%-20K47.38%-1.32M
Cash from discontinued financing activities
Financing cash flow 73,758.91%257.03M-289.09%-208K239,407.50%191.61M-214.81%-31K50,023.66%65.66M-90.18%348K-52.17%110K-91.00%80K-98.05%27K-87.40%131K
Net cash flow
Beginning cash position -53.87%78.84M208.63%226.16M-21.37%59.54M-64.26%61.21M-53.87%78.84M170.25%170.92M-46.11%73.28M-69.53%75.72M48.57%171.27M170.25%170.92M
Current changes in cash 261.19%147.73M-77.69%1.36M6,325.65%166.47M97.61%-2.29M-3,965.73%-17.82M-185.24%-91.65M-82.48%6.08M97.62%-2.67M-171.70%-95.51M-99.11%461K
Effect of exchange rate changes 345.21%1.07M122.48%118K-36.02%151K1,658.97%608K279.09%197K-373.75%-438K-321.52%-525K276.12%236K-116.67%-39K-246.67%-110K
End cash Position 188.74%227.64M188.74%227.64M208.63%226.16M-21.37%59.54M-64.26%61.21M-53.87%78.84M-53.87%78.84M-46.11%73.28M-69.53%75.72M48.57%171.27M
Free cash flow 26.41%-123.48M52.58%-27.99M26.86%-30.39M62.10%-25.27M-7,064.57%-39.84M-1,671.49%-167.8M-547.35%-59.03M-651.92%-41.55M-900.25%-66.67M89.55%-556K
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More